Index | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care |
Investment focus | Equity, World, Health Care, Social/Environmental |
Fund size | GBP 215 m |
Total expense ratio | 0.18% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | Yes |
Fund currency | EUR |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 12.13% |
Inception/ Listing Date | 20 September 2022 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | Amundi ETF |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | HSBC Securities Services (Ireland) DAC |
Investment Advisor | |
Custodian Bank | HSBC BANK PLC |
Revision Company | - |
Fiscal Year End | 31 December |
Swiss representative | NO |
Swiss paying agent | NO |
Germany | 30% tax rebate |
Switzerland | No ESTV Reporting |
Austria | Non-Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
Eli Lilly & Co. | 9.52% |
UnitedHealth Group | 8.94% |
AbbVie, Inc. | 7.15% |
AstraZeneca PLC | 4.81% |
Roche Holding AG | 4.68% |
Novo Nordisk A/S | 4.21% |
Abbott Laboratories | 4.12% |
Novartis AG | 3.59% |
Merck & Co., Inc. | 3.34% |
Sanofi | 2.71% |
United States | 67.11% |
Switzerland | 9.75% |
Japan | 5.03% |
United Kingdom | 5.00% |
Other | 13.11% |
Health Care | 94.50% |
Consumer Discretionary | 0.72% |
Other | 4.78% |
YTD | +7.38% |
1 month | +6.24% |
3 months | +3.08% |
6 months | +0.50% |
1 year | +4.91% |
3 years | - |
5 years | - |
Since inception (MAX) | +14.87% |
2024 | +2.86% |
2023 | +0.11% |
2022 | - |
2021 | - |
Volatility 1 year | 12.13% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | 0.40 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -11.95% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -11.95% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | WELS | - - | - - | - |
SIX Swiss Exchange | USD | WEL9 | WEL9 SW IWEL9 | WEL9.S IWEL9USDINAV=SOLA | BNP Paribas Arbitrage |
XETRA | USD | WEL9 | WEL9 GY IWEL9 | WELSGUSD.DE IWEL9USDINAV=SOLA | BNP Paribas Arbitrage |
XETRA | EUR | WELS | WELS GY IWELS | WELSG.DE IWELSEURINAV=SOLA | BNP Paribas Arbitrage |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 1,017 | 0.40% p.a. | Accumulating | Sampling |
iShares Ageing Population UCITS ETF | 373 | 0.40% p.a. | Accumulating | Sampling |
iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc) | 99 | 0.18% p.a. | Accumulating | Sampling |
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 82 | 0.35% p.a. | Accumulating | Full replication |
Invesco S&P World Health Care ESG UCITS ETF Acc | 70 | 0.18% p.a. | Accumulating | Full replication |